{"id":256,"date":"2021-11-20T11:51:05","date_gmt":"2021-11-20T11:51:05","guid":{"rendered":"http:\/\/localhost:8888\/keith-wordpress\/?post_type=investee&#038;p=256"},"modified":"2021-12-13T09:13:06","modified_gmt":"2021-12-13T09:13:06","slug":"artax","status":"publish","type":"investee","link":"https:\/\/www.keith.vc\/en\/investee\/artax\/","title":{"rendered":"Artax"},"content":{"rendered":"\n<p>Artax Biopharma es una empresa biofarmac\u00e9utica que desarrolla nuevas terapias para enfermedades autoinmunes e inflamatorias. El control espec\u00edfico sobre las c\u00e9lulas T a trav\u00e9s de TCR, proporciona a los compuestos el potencial de convertirse en inmunomoduladores FIRST IN CLASS para el tratamiento de una amplia gama de enfermedades autoinmunes e inflamatorias.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Artax Biopharma es una empresa biofarmac\u00e9utica que desarrolla nuevas terapias para enfermedades autoinmunes e inflamatorias. El control espec\u00edfico sobre las c\u00e9lulas T a trav\u00e9s de TCR, proporciona a los compuestos el potencial de convertirse en inmunomoduladores FIRST IN CLASS para el tratamiento de una amplia gama de enfermedades autoinmunes e inflamatorias.<\/p>\n","protected":false},"author":1,"featured_media":404,"comment_status":"open","ping_status":"open","template":"","tags":[],"mkt_place":[32],"porfolio_stage":[4],"angel_fund":[13],"acf":[],"_links":{"self":[{"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/investee\/256"}],"collection":[{"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/investee"}],"about":[{"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/types\/investee"}],"author":[{"embeddable":true,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/comments?post=256"}],"version-history":[{"count":8,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/investee\/256\/revisions"}],"predecessor-version":[{"id":673,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/investee\/256\/revisions\/673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/media\/404"}],"wp:attachment":[{"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/media?parent=256"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/tags?post=256"},{"taxonomy":"mkt_place","embeddable":true,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/mkt_place?post=256"},{"taxonomy":"porfolio_stage","embeddable":true,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/porfolio_stage?post=256"},{"taxonomy":"angel_fund","embeddable":true,"href":"https:\/\/www.keith.vc\/en\/wp-json\/wp\/v2\/angel_fund?post=256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}